Fundz

ClearPoint Neuro acquires IRRAS for $5 million

PUBLIC · CLPTNov 20, 2025

Acquiring Company

ClearPoint Neuro

Acquired Company

IRRAS Holdings

Solana BeachDelawareBiotechnologyHealthcareHealth CareTherapeuticsManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

ClearPoint Neuro has successfully acquired IRRAS Holdings for $5 million in cash and additional shares. This acquisition will enhance ClearPoint's capabilities in CNS drug delivery and expand its operational scale. The addition of IRRAS's technology and customers is expected to significantly benefit ClearPoint's portfolio in neurocritical care.

Company Information

Company

ClearPoint Neuro

Location

Solana Beach, California, United States

About

ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company uniquely provides both established clinical products as well as preclinical development services for controlled drug and device delivery. The Company's flagship product, the ClearPoint Neuro Navigation System, has FDA clearance and is CE-marked. ClearPoint Neuro is engaged with healthcare and research centers in North America, Europe, Asia, and South America. The Company is also partnered with the most innovative pharmaceutical/biotech companies, academic centers, and contract research organizations, providing solutions for direct central nervous system delivery of therapeutics in preclinical studies and clinical trials worldwide. To date, thousands of procedures have been performed and supported by the Company's field-based clinical specialist team, which offers support and services to our customers and partners worldwide.

Fundz sees it the moment ClearPoint Neuro makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Joe
Senior decision-maker at this company
••••••••@••••••••

See Joe's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ClearPoint Neuro's next move

Learn about Strategic plan

Frequently asked

Who acquired IRRAS Holdings?

IRRAS Holdings was acquired by ClearPoint Neuro, based in Solana Beach. The deal was reported on November 20, 2025. ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. ClearPoint Neuro is publicly traded (CLPT) and operates in Biotechnology.

When did ClearPoint Neuro acquire IRRAS Holdings?

ClearPoint Neuro's acquisition of IRRAS Holdings was reported on November 20, 2025. ClearPoint Neuro has successfully acquired IRRAS Holdings for $5 million in cash and additional shares. This acquisition will enhance ClearPoint's capabilities in CNS drug delivery and expand its operational scale. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does IRRAS Holdings do?

IRRAS Holdings, Inc. is a medical technology company that develops and commercializes innovative therapeutic solutions for various neurological conditions. The company is known for its cutting-edge products aimed at improving patient outcomes in neurosurgery. It is privately held, operating in Manufacturing, and is based in Delaware.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.